|
1
|
Disruption of the SRC-1 gene in mice suppresses breast cancer metastasis without affecting primary tumor formation.
|
Proc Natl Acad Sci U S A
|
2008
|
1.62
|
|
2
|
Molecular structure and biological function of the cancer-amplified nuclear receptor coactivator SRC-3/AIB1.
|
J Steroid Biochem Mol Biol
|
2002
|
1.42
|
|
3
|
Genome-wide DNA methylation profiling of chronic lymphocytic leukemia allows identification of epigenetically repressed molecular pathways with clinical impact.
|
Epigenetics
|
2010
|
1.37
|
|
4
|
Epigenetics of acute lymphocytic leukemia.
|
Semin Hematol
|
2009
|
1.04
|
|
5
|
Haploid inactivation of the amplified-in-breast cancer 3 coactivator reduces the inhibitory effect of peroxisome proliferator-activated receptor gamma and retinoid X receptor on cell proliferation and accelerates polyoma middle-T antigen-induced mammary tumorigenesis in mice.
|
Cancer Res
|
2004
|
1.02
|
|
6
|
Thoracic aortic disease in tuberous sclerosis complex: molecular pathogenesis and potential therapies in Tsc2+/- mice.
|
Hum Mol Genet
|
2010
|
0.96
|
|
7
|
Regulation of insulin secretion and beta-cell mass by activating signal cointegrator 2.
|
Mol Cell Biol
|
2006
|
0.88
|
|
8
|
Paucity of skeletal manifestations in Hispanic families with FBN1 mutations.
|
Eur J Med Genet
|
2009
|
0.87
|
|
9
|
Spatial distribution of the messenger ribonucleic acid and protein of the nuclear receptor coactivator, amplified in breast cancer-3, in mice.
|
Endocrinology
|
2003
|
0.87
|
|
10
|
Preclinical antileukemia activity of JNJ-26481585, a potent second-generation histone deacetylase inhibitor.
|
Leuk Res
|
2009
|
0.85
|
|
11
|
FOXE3 mutations predispose to thoracic aortic aneurysms and dissections.
|
J Clin Invest
|
2016
|
0.78
|